Biogen (BIIB) Spikes 14% After FDA Posts Briefing Documents for Alzheimer's Drug Aducanumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. MSFT
5. DCOY
6. SPY
7. VKTX
8. PRGS
9. CMPX
10. GS

Go back to Biogen (BIIB) Spikes 14% After FDA Posts Briefing Documents for Alzheimer's Drug Aducanumab
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 225.36 +6.29 (2.87%)
Previous Close $219.07    52 Week High $333.65 
Open $219.22    52 Week Low $223.02 
Day High $226.43    P/E 28.86 
Day Low $219.00    EPS $7.81 
Volume 1,112,309